Relationship between survival and erythrocyte sedimentation rate in patients operated for lung cancer

Basit Öğe Kaydı
dc.authoridKavurmacı, Önder/0000-0002-9644-8218
dc.authorscopusid57212532836
dc.authorscopusid55343779100
dc.authorscopusid57194346598
dc.authorscopusid55343710200
dc.authorscopusid37052683100
dc.authorscopusid8429335700
dc.authorscopusid6602854011
dc.authorwosidKavurmacı, Önder/GQQ-2109-2022
dc.contributor.authorTekneci, Ahmet Kayahan
dc.contributor.authorAkcam, Tevfik Ilker
dc.contributor.authorKavurmaci, Onder
dc.contributor.authorOzdil, Ali
dc.contributor.authorTurhan, Kutsal
dc.contributor.authorCakan, Alpaslan
dc.contributor.authorCagirici, Ufuk
dc.date.accessioned2023-01-12T20:19:10Z
dc.date.available2023-01-12T20:19:10Z
dc.date.issued2022
dc.departmentN/A/Departmenten_US
dc.description.abstractBackground: This study aims to investigate the relationship between preoperative erythrocyte sedimentation rate and survival in patients undergoing pulmonary resection due to lung cancer. Methods: Between January 2011 and July 2017, a total of 575 patients (433 males, 142 females; mean age: 61.2 +/- 9.9 years; range, 29 to 82 years) who were operated due to primary lung cancer in our clinic were retrospectively analyzed. The patients were grouped according to erythrocyte sedimentation rate to analyze the relationship between erythrocyte sedimentation rate and survival. Results: The mean overall survival time was 61.8 +/- 1.7 months in 393 patients with an erythrocyte sedimentation rate of <= 24 mm/h and 48.9 +/- 2.9 months in 182 patients with an erythrocyte sedimentation rate of >= 25 mm/h (p<0.001). Among the patients with Stage I-II disease, the mean survival time was 66.2 +/- 1.9 in patients with an erythrocyte sedimentation rate of <= 24 mm/h and 53.8 +/- 3.2 in patients with an erythrocyte sedimentation rate of >= 25 mm/h (p=0.008). The mean survival time in patients with adenocarcinoma was 62.4 +/- 2.4 months in patients with <= 24 mm/h erythrocyte sedimentation rate and 46.1 +/- 4.6 months in patients with >= 25 mm/h erythrocyte sedimentation rate (p=0.003). Conclusion: The relationship between elevated erythrocyte sedimentation rate and poor prognosis in patients with the same stage of the disease is promising for the use of erythrocyte sedimentation rate as a prognostic marker.en_US
dc.identifier.doi10.5606/tgkdc.dergisi.2022.21217
dc.identifier.endpage388en_US
dc.identifier.issn1301-5680
dc.identifier.issue3en_US
dc.identifier.pmid36303686en_US
dc.identifier.scopus2-s2.0-85135385383en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage381en_US
dc.identifier.urihttps://doi.org/10.5606/tgkdc.dergisi.2022.21217
dc.identifier.urihttps://hdl.handle.net/11454/79046
dc.identifier.volume30en_US
dc.identifier.wosWOS:000756656200001en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherBaycinar Medical Publ-Baycinar Tibbi Yayinciliken_US
dc.relation.ispartofTurk Gogus Kalp Damar Cerrahisi Dergisi-Turkish Journal of Thoracic and Cardiovascular Surgeryen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectErythrocyte sedimentation rateen_US
dc.subjectlung canceren_US
dc.subjectpostoperative survivalen_US
dc.titleRelationship between survival and erythrocyte sedimentation rate in patients operated for lung canceren_US
dc.title.alternativeAkciğer kanseri nedeniyle ameliyat edilen hastalarda sağkalım ve eritrosit sedimantasyon hızı arasındaki ilişkien_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu